Semaglutide GLP-1 is a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which treat type 2 diabetes and obesity
Typically, injections are administered 23 times per week initially, followed by maintenance doses
Injection Sites, Storage, and Handling Common handling practices include: Using 2931 g insulin syringes for subcutaneous shots Cleaning the skin with alcohol before injection Storing lyophilized powder at 28 C Refrigerating reconstituted BPC 157 and using it within 14 days Disposing of needles and vials according to biohazard guidelines Medical supervision is recommended, especially for injectable use, long protocols, peptide stacks, or athletes with existing medical conditions
However, recently these medications have gained increasing popularity for weight loss, Knese noted
Retatrutide may provide broader metabolic benefits, while Tirzepatide has extensive real-world use
They work in a similar way as injectable GLP-1s